Search research articles
Contact Us
Filters
Showing results (81-90 of 325) with videos related to
Page
of 33
Sort By:
Hematology. American Society of Hematology. Education Program
|
November 26, 2002
Chronic lymphocytic leukemia
Neil E Kay, Terry J Hamblin, Diane F Jelinek, et al.
Frontiers in Oncology
|
December 19, 2023
Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib
Baustin M Welch, Bryce A Manso, Kimberly A Gwin, et al.
British Journal of Cancer
|
June 17, 2024
Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications
Sutapa Sinha, Ray Guo, Miles D Del Busso, et al.
American Journal of Hematology
|
March 26, 2016
Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemia
Chadi Nabhan, Kari G Chaffee, Susan L Slager, et al.
Clinical Proteomics
|
May 8, 2026
Proteomic and phosphoproteomic signatures of disease progression in unmutated IGHV chronic lymphocytic leukemia
Renee C Tschumper, Neil E Kay, Sameer A Parikh, et al.
Blood
|
July 8, 2010
Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch
Wei Ding, Traci R Knox, Renee C Tschumper, et al.
Leukemia Research
|
July 26, 2005
A recombinant IL-4-Pseudomonas exotoxin inhibits protein synthesis and overcomes apoptosis resistance in human CLL B cells
Neil E Kay, Nancy D Bone, Yean K Lee, et al.
Leukemia Research
|
January 9, 2008
MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?
Tait D Shanafelt, Neil E Kay, Tim G Call, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2012
Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia
Bruce D Cheson, John C Byrd, Kanti R Rai, et al.
Blood Cancer Journal
|
May 18, 2021
SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis
Guru P Maiti, Sutapa Sinha, Hasan Mahmud, et al.
Page
of 33
Search research articles
Search
Showing results (81-90 of 325) with videos related to
Sort By:
Page
of 33
Hematology. American Society of Hematology. Education Program
|
November 26, 2002
Chronic lymphocytic leukemia
Neil E Kay, Terry J Hamblin, Diane F Jelinek, et al.
Frontiers in Oncology
|
December 19, 2023
Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib
Baustin M Welch, Bryce A Manso, Kimberly A Gwin, et al.
British Journal of Cancer
|
June 17, 2024
Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications
Sutapa Sinha, Ray Guo, Miles D Del Busso, et al.
American Journal of Hematology
|
March 26, 2016
Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemia
Chadi Nabhan, Kari G Chaffee, Susan L Slager, et al.
Clinical Proteomics
|
May 8, 2026
Proteomic and phosphoproteomic signatures of disease progression in unmutated IGHV chronic lymphocytic leukemia
Renee C Tschumper, Neil E Kay, Sameer A Parikh, et al.
Blood
|
July 8, 2010
Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch
Wei Ding, Traci R Knox, Renee C Tschumper, et al.
Leukemia Research
|
July 26, 2005
A recombinant IL-4-Pseudomonas exotoxin inhibits protein synthesis and overcomes apoptosis resistance in human CLL B cells
Neil E Kay, Nancy D Bone, Yean K Lee, et al.
Leukemia Research
|
January 9, 2008
MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?
Tait D Shanafelt, Neil E Kay, Tim G Call, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2012
Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia
Bruce D Cheson, John C Byrd, Kanti R Rai, et al.
Blood Cancer Journal
|
May 18, 2021
SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis
Guru P Maiti, Sutapa Sinha, Hasan Mahmud, et al.
Page
of 33